- Israel
- /
- Medical Equipment
- /
- TASE:PULS
Pulsenmore Full Year 2022 Earnings: ₪0.46 loss per share (vs ₪0.62 loss in FY 2021)
Pulsenmore (TLV:PULS) Full Year 2022 Results
Key Financial Results
- Net loss: ₪22.1m (loss narrowed by 14% from FY 2021).
- ₪0.46 loss per share (improved from ₪0.62 loss in FY 2021).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Pulsenmore shares are down 8.6% from a week ago.
Risk Analysis
You still need to take note of risks, for example - Pulsenmore has 2 warning signs we think you should be aware of.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TASE:PULS
Pulsenmore
Engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening.
Moderate with adequate balance sheet.
Market Insights
Community Narratives

